AngioBio

AngioBio is a biotechnology company based in Del Mar, California, that specializes in the development and supply of high-quality antibodies and reagents for the life sciences research community. The company focuses primarily on the fields of angiogenesis, lymphangiogenesis, and tumor biology, providing essential tools for studying vascular development and cancer progression. Their product portfolio includes monoclonal and polyclonal antibodies, recombinant proteins, and ELISA kits targeting key markers such as VEGF, VEGFR, and various adhesion molecules. AngioBio serves academic institutions, pharmaceutical companies, and biotechnology firms worldwide, supporting basic and translational research in oncology and cardiovascular diseases.